Morning Overview on MSN
An experimental Alzheimer’s immune therapy cleared its first safety trial with positive results
An experimental antibody designed to briefly block the immune checkpoint PD-L1 in the brain has cleared its first human ...
Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from ...
Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from ...
UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the response to lung cancer immunotherapy treatment in mice and can now be made ...
Immune-checkpoint therapy (ICT), which attempts to harness a patient's own immune system to fight cancer, has revolutionized cancer care over the past two decades. However, many patients do not ...
Immune checkpoint inhibitors have transformed the management of advanced malignancies by releasing the brakes on antitumour T-cell responses. Agents targeting programmed cell death protein 1 (PD-1), ...
SER-155 recipients achieved immunosuppressive-free clinical response of diarrhea (a primary symptom of irEC) at Day 15 in the ...
Real-world analysis of adverse events associated with KIMMTRAK in metastatic uveal melanoma using the FAERS database. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
South Korean researchers have identified why immune checkpoint inhibitors fail to work against brain tumors such as ...
Prostate cancer is often resistant to immunotherapy, which harnesses a person's immune system to recognize and destroy tumors ...
Cancer immunotherapy has revolutionized oncology, with immune checkpoint inhibitors (ICIs) becoming integral components of modern anti-cancer treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results